Health Care; Pharmaceutical; Diagnostic; Biotech; Medical Device; Manufacturing; Consumer Products; Chemical
Abbott; AbbVie; Amgen; Astellas; Baxter; Bayer; Boehringer Ingelheim; Cutanea; Eli Lilly; EMD Serono; Genentech; GlaxoSmithKline; Grunenthal; Inspire; Ipsen; Lundbeck; Nektar; Novartis; Noven; Novo Nordisk; Pharmacyclics; Regeneron; Roche; Sebela; Servier; Shire; Teva; Zydus Cadila
Because this is a fast changing, highly competitive industry, pharmaceutical companies can no longer rely on past experiences when budgeting for a new product launch. In order for companies to ensure a successful U.S. market entry, we developed this benchmark.
This report provides exclusive new data on the cost of launching a pharmaceutical product in today’s market. This data will guide brand leaders in the critical budget-planning process to ensure that funding levels are adequate and launch activities are well-prioritized and well-timed over the three years before product launch and during launch year. The study identifies current investment levels needed for marketing programs, educational activities and market-access efforts required to bring a new successful drug to market. The report will also focus on top success factors for successful product launches.